A Daiichi Sankyo Group Company
2005-01-01
Japan
Pharmaceutical development and manufacturing
Research and development of new drugs
Marketing and sales of pharmaceutical products
Pharmaceuticals
Research and Development
Biopharmaceuticals
Pharmaceutical research and development
Oncology drug development
Manufacturing and distribution of medicines
Expanded access to investigational products
Clinical trials and drug approval
Manufacturing of active pharmaceutical ingredients
Pharmaceutical distribution and marketing
Tokyo, Japan
Yoshihiro Kondo
1,000,000,000 JPY (10 100 millionJPY)
Company name
Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Daiichi Sankyo Co., LTD.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group

+ Loaded when opened
2026-09-21 18:08 (Model: ggml-org/gpt-oss-20b )
↑